                         SEQUENCE LISTING

<110>  University of Miami
 
<120>  REAGENTS, PHARMACEUTICAL FORMULATIONS, AND METHODS FOR TREATING 
       AND PREVENTING VIRAL INFECTION

<130>  20-989-WO

<150>  63/041,100
<151>  2020-06-18

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Met Val Arg Ile Lys Pro Ala Ser Ala Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

Met Val Arg Ile Lys Pro Gly Thr Ala Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Met Val Arg Ile Lys Pro Gly Thr Ala Asn Lys Pro Thr Asp Asp 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  4

Met Val Arg Ile Lys Pro Gly Ser Gly Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Met Val Arg Ile Lys Pro Ala Thr Ala Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Met Val Arg Ile Lys Pro Gly Thr Gly Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Met Val Arg Ile Lys Pro Gly Thr Gly Asn Lys Pro Thr Asp Asp 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  8

Met Val Arg Ile Lys Pro Ala Thr Ala Asn Lys Pro Thr Asp Asp 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Met Val Arg Ile Lys Pro Ala Thr Gly Asn Lys Pro Thr Asp Asp 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Met Val Arg Ile Lys Pro Ala Thr Gly Asn Lys Pro Ser Asp Asp 
1               5                   10                  15  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Val Arg Leu Lys Pro Ala Ser Ala Asn Lys Pro Ser Glu Asp 
1               5                   10                  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  12

Val Arg Leu Lys Pro Ala Ser Gly Asn Lys Pro Ser Glu Asp 
1               5                   10                  


<210>  13
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  13

Val Arg Leu Lys Pro Gly Ser Gly Asn Lys Pro Ser Glu Asp 
1               5                   10                  


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  14

Val Arg Leu Lys Pro Ala Thr Gly Asn Lys Pro Thr Glu 
1               5                   10              


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  15

Val Arg Leu Lys Pro Gly Thr Ala Asn Lys Pro Thr Glu Asp 
1               5                   10                  


<210>  16
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  16

Val Arg Leu Lys Pro Ala Thr Ala Asn Lys Pro Thr Glu Asp 
1               5                   10                  


<210>  17
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  17

Val Arg Leu Lys Pro Gly Thr Gly Asn Lys Pro Thr Glu Asp 
1               5                   10                  


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  18

Val Arg Leu Lys Pro Gly Thr Ala Asn Lys Pro Ser Glu Asp 
1               5                   10                  


<210>  19
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  19

Val Arg Ile Lys Pro Gly Thr Ala Asn Lys Pro Ser Glu Asp 
1               5                   10                  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X can be M or no amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X can be I or L.

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X can be G or A

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X can be S or T

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X can be A or G

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X can be S or T

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X can be D or E.

<400>  20

Xaa Val Arg Xaa Lys Pro Xaa Xaa Xaa Asn Lys Pro Xaa Xaa Asp 
1               5                   10                  15  


